Fatty liver in morbidly obese humans is not caused by a deficiency of choline or carnitine in plasma.

被引：0
|
作者：
Sheard, NF
Spaulding, L
Zeisel, SH
机构：
[1] UNIV VERMONT,DEPT NUTR SCI,BURLINGTON,VT 05405
[2] UNIV VERMONT,DEPT MED,BURLINGTON,VT 05405
[3] UNIV VERMONT,DEPT SURG,BURLINGTON,VT 05405
[4] UNIV N CAROLINA,DEPT NUTR,CHAPEL HILL,NC 27599
来源：
FASEB JOURNAL | 1997年 / 11卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：3438 / 3438
页数：1
相关论文
共 50 条
  • [21] SERUM AND LIVER AMYLASE AND TRANSAMINASE ACTIVITIES IN CHOLINE DEFICIENCY FATTY LIVER AND CIRRHOSIS
    WINAWER, SJ
    BROITMAN, SA
    GOTTLIEB, LS
    ZAMCHECK, N
    GASTROENTEROLOGY, 1965, 48 (02) : 216 - &
  • [22] Hepatic Gene Networks in Morbidly Obese Patients With Nonalcoholic Fatty Liver Disease
    Samer Gawrieh
    Tesfaye M. Baye
    Melanie Carless
    James Wallace
    Richard Komorowski
    David E. Kleiner
    Deborah Andris
    Bassem Makladi
    Regina Cole
    Michael Charlton
    Joanne Curran
    Thomas D. Dyer
    Jac Charlesworth
    Russell Wilke
    John Blangero
    Ahmed H. Kissebah
    Michael Olivier
    Obesity Surgery, 2010, 20 : 1698 - 1709
  • [23] Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese
    Strey, Claudia B. M.
    de Carli, Luiz A.
    Pioner, Sergio R.
    Fantinelli, Marciane
    Gobbato, Sabrina S.
    Bassols, Guilherme F.
    Losekann, Alexandre
    Coral, Gabriela P.
    ANNALS OF HEPATOLOGY, 2018, 17 (04) : 585 - 591
  • [24] THE APPLICATION OF LIPIDOMIC ANALYSIS ON NONALCOHOLIC FATTY LIVER DISEASE IN MORBIDLY OBESE PATIENTS
    Hsieh, Yin-Ru
    Wu, Hua-Chien
    Wang, Weu
    Chang, Ching-Wen
    Chang, I-Wei
    Chen, Chi-Long
    Chang, Chun-Chao
    Kao, Wei-Yu
    Huang, Shih-Yi
    HEPATOLOGY, 2023, 78 : S885 - S885
  • [25] Prediction of advanced fibrosis in morbidly obese patients with nonalcoholic fatty liver disease
    Singh, Tavankit
    Rocio, Lopez
    Dasarathy, Srinivasan
    McCullough, Arthur J.
    HEPATOLOGY, 2017, 66 : 1123A - 1124A
  • [26] Ursodeoxycholic Acid for Treatment of Fatty Liver Disease and Dyslipidemia in Morbidly Obese Patients
    Marschall, Hanns-Ulrich
    Wagner, Martin
    Zollner, Gernot
    Fickert, Peter
    Lackner, Caroline
    Thorell, Anders
    Trauner, Michael
    DIGESTIVE DISEASES, 2011, 29 (01) : 117 - 118
  • [27] Hepatic Gene Networks in Morbidly Obese Patients With Nonalcoholic Fatty Liver Disease
    Gawrieh, Samer
    Baye, Tesfaye M.
    Carless, Melanie
    Wallace, James
    Komorowski, Richard
    Kleiner, David E.
    Andris, Deborah
    Makladi, Bassem
    Cole, Regina
    Charlton, Michael
    Curran, Joanne
    Dyer, Thomas D.
    Charlesworth, Jac
    Wilke, Russell
    Blangero, John
    Kissebah, Ahmed H.
    Olivier, Michael
    OBESITY SURGERY, 2010, 20 (12) : 1698 - 1709
  • [28] HEPATIC CHEMERIN MRNA IN MORBIDLY OBESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Kajor, Maciej
    Kukla, Michal
    Waluga, Marek
    Liszka, Lukasz
    Dyaczynski, Michal
    Kowalski, Grzegorz
    Zadlo, Dominika
    Berdowska, Agnieszka
    Chapula, Mateusz
    Kostrzb-Zdebel, Anna
    Buldak, Rafal J.
    Sawczyn, Tomasz
    Hartleb, Marek
    POLISH JOURNAL OF PATHOLOGY, 2017, 68 (02) : 117 - 127
  • [29] Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
    Alqahtani, Saleh A.
    Golabi, Pegah
    Paik, James M.
    Lam, Brian
    Moazez, Amir H.
    Elariny, Hazem A.
    Goodman, Zachary
    Younossi, Zobair M.
    OBESITY SURGERY, 2021, 31 (05) : 2002 - 2010
  • [30] Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
    Merriman, Raphael B.
    Ferrell, Linda D.
    Patti, Marco G.
    Weston, Shiobhan R.
    Pabst, Mark S.
    Aouizerat, Bradley E.
    Bass, Nathan M.
    HEPATOLOGY, 2006, 44 (04) : 874 - 880
12345